Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAH
Sponsor: Silvia Ulrich Somaini
Summary
To study the effect of a re-ascent after a one-week stay at sea level (after prior descent from 2850m) to high altitude (Quito Ecuador: 2850m) on pulmonary resistance (sPAP/CO) and other hemodynamic outcomes in patients with pulmonary arterial hypertension PAH, who live permanently \>2600m.
Official title: Effect of a One-week Descent From 2850m to Sea Level and Re-ascent in Patients With Pulmonary Arterial Hypertension and Healthy Controls Permanently Living > 2600m on Pulmonary Hemodynamics, Exercise Capacity, Blood Oxygenation, Sleep Disordered Breathing and Further Outcomes
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-09-25
Completion Date
2026-12-31
Last Updated
2026-09-04
Healthy Volunteers
No
Conditions
Interventions
Re-Ascent from sea level to 2850m
After 7 days at sea level return/re-ascent to their usual living altitude at 2850m
Locations (1)
University Hospital of Zurich
Zurich, Switzerland